Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Mitogenic, immunoadjuvancy, and genetic studies on fatty acyl maltose

  • 13 Accesses

Summary

Three synthetic glycolipids, maltose tetrapalmitate (MTP), maltose hexastearate (MHS), and maltose hexalinoleate (MHL) prepared as nontoxic lipid A analogs, and Escherichia coli lipopolysaccharide (LPS) were assayed for their mitogenic activity using spleen lymphocytes in nine inbred mouse strains and three F1 hybrids. The MTP and LPS were also assayed for their ability to enhance plaque-forming cell (PFC) responses using sheep red blood cells as the antigen in th same inbred mouse strains and F1 hybrids, The mitogenic activity of synthetic glycolipids was several fold lower than that of LPS and MHL was inferior to MTP and MHS. DBA/2J was the most responsive strain for MTP and DBA/1J and C3H/HeJ the least. The mitogenic activity of MTP was generally in agreement with the PFC response stimulation by it. Lowdose cyclophosphamide treatment of mice synergized MTP for PFC response augmentation. Genetic studies on MTP mitogenicity revealed that 90% of responder DBA/2J X nonresponder C3H/HeJ F1 hybrids had intermediate mitogenic activity. Among F2, 73% had intermediate-high activity and 27% were nonmitogenic. Among F1 X C3H/HeJ backcrosses 11% had high, 56% intermediate, and 33% had no mitogenic activity, whereas, for the F1 X DBA/2J backcross, 14% had high, 36% intermediate, and 50% low or negligible activity. The data favored a single gene for MTP activation of immune cells.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Behling UH, Campbell B, Chang CM, Rumpf C, Nowotny A (1979) Synthetic glycolipid adjuvants. J Immunol 117:847

  2. 2.

    Benedetto DA, Shands JW Jr, Shah DO (1973) The interaction of bacterial lipopolysaccharide with phospholipid bilayers and monolayers. Biochim Biophys Acta 298:145

  3. 3.

    Benrezzak O, Nigam VN, Madarnas P, Pageau R (1986) Induction of colorectal and epidermoid anal cancer by dimethylhydrazine in CD1 mice and the evaluation of single and combined therapy regimens. Proc Am Assoc Can Res 27:738

  4. 4.

    Benrezzak O, Nigam VN, Madarnas P, Pageau R (1987) Combined modality treatment of primary lung cancer in A/J mice with maltose tetrapalmitate, radiotherapy and cyclophosphamide. Proc Am Assoc Can Res 28:450

  5. 5.

    Bonaventure J, Nigam VN, Brailovsky CA (1984) In vitro spleen cell proliferation following in vivo treatment with a synthetic glycolipid or lipid A in three mouse strains. Int J Immunopharmacol 6:259

  6. 6.

    Cunningham, Szenberg A (1968) Further improvements in the plaque technique for detecting single antibody forming cells. Immunology 14:599

  7. 7.

    Hersh EM, Gutterman JU, Mavligit GN (1977) Immunotherapy of human cancer. Adv Int Med 22:145

  8. 8.

    Hoffmann MK, Weiss O, Koenig S, Hirst JA, Oettgen HF (1975) Suppression and enhancement of T cell dependent production of antibody to SRBC in vitro by bacterial lipopolysaccharide. J Immunol 114:738

  9. 9.

    Ibraheim HE, Nigam VN, Brailovsky CA, Backman BD, Elhilali MM (1984) Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted prostate and bladder carcinoma of the rat. Cancer Res 44:546

  10. 10.

    Ibraheim HE, Kappany H, Nigam VN, Brailovsky CA, Madarnas P, Elhilali MM (1984) Adjuvant immunotherapy of N-[4-(5[nitro-2-furyl)-2-thiazolyl] formamide-induced bladder tumors. Anticancer Res 4:209

  11. 11.

    Ibraheim HE, Kappany H, Elhilali MM, Nigam VN, Brailovsky CA (1985) Prophylactic maltose tetrapalmitate and BCG immunotherapy for recurrent superficial bladder tumors. Proc Am Urol Assoc 80:211A

  12. 12.

    Jakway JP, Defranco AL (1986) Pertussis toxin inhibition of B-cell and macrophage responses to bacterial lipopolysaccharide. Science 234:743

  13. 13.

    Kappany H, Chopra C, Nigam VN, Brailovsky CA, Elhilali MM (1980) A comparison of the antitumor activity of maltose tetrapalmitate with other immunoadjuvants and its effectiveness after tumor surgery. Br J Cancer 42:703

  14. 14.

    Kato A, Ando K, Tamura G, Arima J (1971) Effects of some fatty acid esters on the viability and transplantability of Ehrlich ascites tumor cells. Cancer Res 31:501

  15. 15.

    Kotani S, Takada H, Tsuijimoto M, Ogawa T, Harada K, Mori Y, Kawasaki A, Tanaka A, Nagao S, Tanaka S, Shiba T, Kusumoto S, Imoto M, Yoshimura H, Yamamoto M, Shimamoto T (1984) Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A. Infect Immun 45:293

  16. 16.

    Kotani S, Takada H, Tsuijimoto M, Ogawa T, Mori Y, Sakuta M, Kawasaki A, Inage M, Kusumoto S, Shiba T, Kasai N (1984) Immunobiological activities of synthetic lipid A analogs and related compounds as compared to those of bacterial lipopolysaccharide, reglycolipid, lipid A and muramyl dipeptide. Infect Immun 41:758

  17. 17.

    Munford RS, Hall CF (1986) Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234:203

  18. 18.

    News Item. Sucrose polyester lowers cholesterol levels (1978) Chem Eng News Dec 4, p 26

  19. 19.

    Nigam VN, Brailovsky CA, Chopra C (1978) Maltose tetrapalmitate: a non-toxic immunopotentiator with antitumor activity. Cancer Res 38:3315

  20. 20.

    Nigam VN, Bonaventure J, Chopra C, Brailovsky CA (1982) Effects of structural variation in synthetic glycolipids upon mitogenicity for spleen lymphocytes, adjuvancy for humoral immune response and on antitumor potential. Br J Cancer 46:782

  21. 21.

    Nigam VN, Brière N, Bonaventure J, Pageau R, Bissonnette E, Brailovsky CA, Madarnas P (1986) Combined radiotherapy, chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of 4′-dimethyl-aminoazobenzene-induced liver cancer. Anticancer Res 6:245

  22. 22.

    Nishikawa Y, Yoshimoto K, Nishijima M, Fukuoka F, Ikekawa T (1981) Chemical and biochemical studies on carbohydrate esters IX. Antitumor effects of selectively fatty acylated products of maltose. Chem Pharm Bull 29:505

  23. 23.

    Nishizuka Y (1984) Turnover of inositol phospholipids and signal transduction. Science 225:1365

  24. 24.

    Pageau R, Nigam VN, Fisher GJ, Brailovsky CA, Fathi MA, Corcos J, Tahan TW, Elhilali MM (1985) Combination of 60Co Y-radiation, misonidazole and maltose tetrapalmitate in the treatment of Dunning prostatic tumor in the rat. Int J Rad Oncol Biol Phys 11:1483

  25. 25.

    Rollinghoff MA, Starzinski-Powitz K, Pfizenmaier K, Wagner H (1977) Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen specific cytotoxic T lymphocytes. J Exp Med 145:455

  26. 26.

    Rosenstreich DL, Asselineau J, Mergenhagen SE, Nowotny A (1974) Synthetic glycolipid with B cell mitogenic activity. J Exp Med 140:1404

  27. 27.

    Tanamoto KI, Galanos C, Luderitz O, Shiba T (1984) Mitogenic activities of synthetic lipid A analogs and suppression of mitogenicity of lipid A. Infect Immun 44:427

  28. 28.

    Tanamoto KI, Zhringer U, McKenzie GR, Galanos C, Rietschel ETH, Luderitz O, Kusumoto S, Shiba T (1984) Biological activities of synthetic lipid A. Analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of limulus amoebocyte lysate. Infect Immun 44:421

  29. 29.

    Watson J, Riblet R (1974) Genetic control of responses to bacterial lipopolysaccharides in mice I. Evidence for a single gene that influences mitogenic and immunogenic responses to lipopolysaccharides. J Exp Med 140:1147

  30. 30.

    Watson J, Riblet R, Taylor BA (1977) The responses of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol 118:2088

Download references

Author information

Additional information

This work was supported, in part, by a grant from the National Cancer Institute of Canada, and by grant from the Cancer Research Society Inc.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bissonnette, E., Benrezzak, O., Madarnas, P. et al. Mitogenic, immunoadjuvancy, and genetic studies on fatty acyl maltose. Cancer Immunol Immunother 27, 272–277 (1988). https://doi.org/10.1007/BF00205451

Download citation

Keywords

  • Escherichia Coli
  • Cyclophosphamide
  • Genetic Study
  • Maltose
  • Fatty Acyl